blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2734504

EP2734504 - POLYMORPHIC FORMS OF COMPOUNDS AS PROLYL HYDROXYLASE INHIBITOR, AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.07.2017
Database last updated on 02.09.2024
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Beijing Betta Pharmaceuticals Co., Ltd
Building 29, Zone-B
BPU Software Park
1 North Disheng Street
Business Development Area, Daxing
Beijing 100176 / CN
[2016/37]
Former [2014/22]For all designated states
Beijing Betta Pharmaceuticals Co., Ltd
Building 29, Zone-B
BPU Software Park
1 North Disheng Street
Business Development Area, Daxing
Beijing 100176 / CN
For all designated states
Kang, Xinshan
Building 29, Zone B
BPU Software Park
1 North Disheng St.
Business Development Area
Daxing, Beijing 100176 / CN
Inventor(s)01 / KANG, Xinshan
Building 1
20 North Jinzhou Rd.
Cangshan District
Fuzhou
Fujian 350002 / CN
02 / LONG, Wei
Bld 29
Zone-B
BPU Software Park
1 North Disheng St., Business Development Area, Daxing
Beijing 100176 / CN
03 / ZHANG, Jianxi
Bld 29
Zone-B
BPU Software Park
1 North Disheng St., Business Development Area, Daxing
Beijing 100176 / CN
04 / HU, Yunyan
Bld 29
Zone-B
BPU Software Park
1 North Disheng St., Business Development Area, Daxing
Beijing 100176 / CN
05 / WANG, Yinxiang
Bld 29
Zone-B
BPU Software Park
1 North Disheng St., Business Development Area, Daxing
Beijing 100176 / CN
 [2014/22]
Representative(s)Gulde & Partner
Patent- und Rechtsanwaltskanzlei mbB
Wallstraße 58/59
10179 Berlin / DE
[2014/22]
Application number, filing date12817360.623.07.2012
[2016/37]
WO2012CN79058
Priority number, dateCN20111020717522.07.2011         Original published format: CN201110207175
CN20111020965725.07.2011         Original published format: CN201110209657
CN20111021129726.07.2011         Original published format: CN201110211297
[2014/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013013609
Date:31.01.2013
Language:EN
[2013/05]
Type: A1 Application with search report 
No.:EP2734504
Date:28.05.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 31.01.2013 takes the place of the publication of the European patent application.
[2014/22]
Type: B1 Patent specification 
No.:EP2734504
Date:14.09.2016
Language:EN
[2016/37]
Search report(s)International search report - published on:CN31.01.2013
(Supplementary) European search report - dispatched on:EP01.12.2014
ClassificationIPC:C07D217/26, A61K31/472, A61P3/10, A61P7/06, A61P9/12, A61P17/02, A61P29/00, A61P35/00, A61P37/06, A61P43/00
[2014/22]
CPC:
C07D217/26 (EP,CN,US); A61K31/472 (EP,US); A61P17/02 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P35/00 (EP);
A61P37/06 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P7/06 (EP); A61P9/10 (EP); A61P9/12 (EP);
C07B2200/13 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/22]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:POLYMORPHE FORMEN VON VERBINDUNGEN ALS PROLYLHYDROXYLASEHEMMER UND VERWENDUNGEN DAVON[2014/22]
English:POLYMORPHIC FORMS OF COMPOUNDS AS PROLYL HYDROXYLASE INHIBITOR, AND USES THEREOF[2014/22]
French:FORMES POLYMORPHES DE COMPOSÉS EN TANT QU'INHIBITEUR DE PROLYLE HYDROXYLASE ET LEURS UTILISATIONS[2014/22]
Entry into regional phase21.02.2014National basic fee paid 
21.02.2014Search fee paid 
21.02.2014Designation fee(s) paid 
21.02.2014Examination fee paid 
Examination procedure21.02.2014Examination requested  [2014/22]
29.06.2015Amendment by applicant (claims and/or description)
14.10.2015Despatch of a communication from the examining division (Time limit: M04)
10.02.2016Reply to a communication from the examining division
13.04.2016Communication of intention to grant the patent
20.07.2016Fee for grant paid
20.07.2016Fee for publishing/printing paid
20.07.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.10.2015
Opposition(s)15.06.2017No opposition filed within time limit [2017/34]
Fees paidRenewal fee
31.01.2015Renewal fee patent year 03
27.07.2015Renewal fee patent year 04
27.07.2016Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.07.201403   M06   Fee paid on   31.01.2015
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.07.2012
AL14.09.2016
AT14.09.2016
BE14.09.2016
CY14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
HR14.09.2016
LT14.09.2016
LV14.09.2016
MC14.09.2016
MK14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
RS14.09.2016
SE14.09.2016
SI14.09.2016
SK14.09.2016
SM14.09.2016
TR14.09.2016
BG14.12.2016
NO14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
[2020/15]
Former [2019/51]HU23.07.2012
AL14.09.2016
AT14.09.2016
BE14.09.2016
CY14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
HR14.09.2016
LT14.09.2016
LV14.09.2016
MC14.09.2016
MK14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
RS14.09.2016
SE14.09.2016
SI14.09.2016
SK14.09.2016
SM14.09.2016
BG14.12.2016
NO14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2019/46]HU23.07.2012
AL14.09.2016
AT14.09.2016
BE14.09.2016
CY14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
HR14.09.2016
LT14.09.2016
LV14.09.2016
MC14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
RS14.09.2016
SE14.09.2016
SI14.09.2016
SK14.09.2016
SM14.09.2016
BG14.12.2016
NO14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2019/31]HU23.07.2012
AL14.09.2016
AT14.09.2016
BE14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
HR14.09.2016
LT14.09.2016
LV14.09.2016
MC14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
RS14.09.2016
SE14.09.2016
SI14.09.2016
SK14.09.2016
SM14.09.2016
BG14.12.2016
NO14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2019/30]AL14.09.2016
AT14.09.2016
BE14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
HR14.09.2016
LT14.09.2016
LV14.09.2016
MC14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
RS14.09.2016
SE14.09.2016
SI14.09.2016
SK14.09.2016
SM14.09.2016
BG14.12.2016
NO14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2018/47]AL14.09.2016
AT14.09.2016
BE14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
HR14.09.2016
LT14.09.2016
LV14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
RS14.09.2016
SE14.09.2016
SI14.09.2016
SK14.09.2016
SM14.09.2016
BG14.12.2016
NO14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2017/52]AT14.09.2016
BE14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
HR14.09.2016
LT14.09.2016
LV14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
RS14.09.2016
SE14.09.2016
SI14.09.2016
SK14.09.2016
SM14.09.2016
BG14.12.2016
NO14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2017/34]AT14.09.2016
BE14.09.2016
CZ14.09.2016
DK14.09.2016
EE14.09.2016
FI14.09.2016
HR14.09.2016
LT14.09.2016
LV14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
RS14.09.2016
SE14.09.2016
SK14.09.2016
SM14.09.2016
BG14.12.2016
NO14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2017/32]AT14.09.2016
BE14.09.2016
CZ14.09.2016
EE14.09.2016
FI14.09.2016
HR14.09.2016
LT14.09.2016
LV14.09.2016
NL14.09.2016
PL14.09.2016
RO14.09.2016
RS14.09.2016
SE14.09.2016
SK14.09.2016
SM14.09.2016
BG14.12.2016
NO14.12.2016
GR15.12.2016
IS14.01.2017
PT16.01.2017
Former [2017/13]FI14.09.2016
HR14.09.2016
LT14.09.2016
LV14.09.2016
NL14.09.2016
RS14.09.2016
SE14.09.2016
NO14.12.2016
GR15.12.2016
Former [2017/11]FI14.09.2016
HR14.09.2016
LT14.09.2016
RS14.09.2016
SE14.09.2016
NO14.12.2016
GR15.12.2016
Former [2017/10]FI14.09.2016
HR14.09.2016
LT14.09.2016
RS14.09.2016
SE14.09.2016
NO14.12.2016
Former [2017/09]FI14.09.2016
LT14.09.2016
NO14.12.2016
Former [2017/07]LT14.09.2016
Documents cited:Search[ID]WO2004108681  (FIBROGEN INC [US], et al) [ID] 1-40 * D-81 on pages 211-212; paragraph [0002] *;
 [I]WO2006133391  (FIBROGEN INC [US], et al) [I] 1-40* Compound B on page 5; page 3 *;
 [I]WO2007146438  (FIBROGEN INC [US], et al) [I] 1-40 * Compound D on page 54, lines 14-15; page 4, line 26 - line 28 *
International search[X]CN101394843  (FIBROGEN INC [US]);
 [X]CN101500569  (FIBROGEN INC [US])
by applicantWO2004108681
 WO2006133391
 WO2007070359
 WO2007146438
 US2008004817
 WO2011006355
    - DAO JH ET AL., ANAL BIOCHEM., (2009), vol. 384, pages 213 - 23
    - ROBINSON A ET AL., GASTROENTEROLOGY, (2008), vol. 134, pages 145 - 55
    - HSIEH MM ET AL., BLOOD, (2007), vol. 110, pages 2140 - 7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.